Personalized medicine and global health-Reference-Cited by-同舟云学术

Personalized medicine and global health

Published:2017-09-01 Issue:3 Volume:25 Page:244-248
ISSN:1876-4851
Container-title:Public Health Forum
language:en
Short-container-title:

Author:

Kohler Stefan¹²

Affiliation:

1. Heidelberg University , Institute of Public Health , Im Neuenheimer Feld 130.3 , 69120 Heidelberg

2. Charité – Universitätsmedizin Berlin , Berlin

Abstract

Abstract More and more new drug substances are personalized medicines. Their impact on population health is globally small because mortality from many major causes of death is not reduced. More than half of all deaths worldwide can be attributed to behavioral, environmental and occupational, or metabolic risks. Broad personalized medicine approaches, which collect and use information also to better target interventions on major health risks are needed to improve global population health.

Publisher

Walter de Gruyter GmbH

Subject

Public Health, Environmental and Occupational Health

Link

https://www.degruyter.com/document/doi/10.1515/pubhef-2017-0032/pdf

Reference29 articles.

1. Redekop WK, Mladsi D. The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health 2013;16:S4–9.

2. Schleidgen S, Klingler C, Bertram T, Rogowski WH, Marckmann G. What is personalized medicine: sharpening a vague term based on a systematic literature review. BMC Med Ethics 2013;14:55.

3. Di Paolo A, Sarkozy F, Ryll B, Siebert U. Personalized medicine in Europe: not yet personal enough? BMC Health Serv Res 2017;17:289.

4. Vijverberg SJ, Maitland-van der Zee A-H. Priority Medicines for Europe and the World “A Public Health Approach to Innovation”. Background Paper 7.4: Pharmacogenetics and Stratified Medicine, Geneva: World Health Organization, 2013.

5. Joyner MJ, Paneth N. Seven questions for personalized medicine. J Am Med Assoc 2015;314:999–1000.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Industrial application of metabolomics for personalized medicine: Current status and challenges;Metabolomics;2023

2. Personalized medicine drugs and the burden of disease in Germany;Journal of Pharmaceutical Health Services Research;2021-05-27

3. Usage of a German prevention and health promotion web portal and cost per pageview: A life-cycle assessment;DIGITAL HEALTH;2019-01